Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
76.87
+0.81 (1.06%)
Aug 10, 2026, 12:24 PM EDT - Market open

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,9983,1471,4341,2361,044813
Market Cap Growth
147.35%119.41%16.06%18.37%28.45%-32.56%
Enterprise Value
5,4812,7431,2011,042859.38636.69
Last Close Price
76.8741.2519.7817.5414.9811.77
PE Ratio
77.6955.00-87.705.76-
Forward PE
52.7527.3242.93170.84170.84-
PS Ratio
7.064.643.394.574.7421.09
PB Ratio
9.075.543.272.822.644.39
P/TBV Ratio
9.845.903.352.992.794.87
P/FCF Ratio
32.4623.0756.4493.83183.11-
P/OCF Ratio
32.0822.8155.8492.92179.80-
EV/Sales Ratio
6.444.052.843.853.9016.52
EV/EBITDA Ratio
53.0934.82--70.59-
EV/EBIT Ratio
54.0435.52--87.93-
EV/FCF Ratio
29.6320.1047.2579.10150.72-
Debt / Equity Ratio
0.010.010.020.020.010.01
Debt / EBITDA Ratio
0.090.12--0.49-
Debt / FCF Ratio
0.050.070.390.931.04-
Net Debt / Equity Ratio
-0.79-0.71-0.53-0.44-0.47-0.95
Net Debt / EBITDA Ratio
-5.07-5.145.328.49-15.171.14
Net Debt / FCF Ratio
-2.83-2.97-9.20-14.74-32.391.39
Asset Turnover
1.011.010.760.550.640.13
Inventory Turnover
1.361.912.121.271.814.95
Quick Ratio
3.213.092.843.584.484.15
Current Ratio
3.903.793.304.345.164.38
Return on Equity (ROE)
13.20%11.73%-9.85%3.37%63.10%-63.55%
Return on Assets (ROA)
9.49%7.63%-9.85%4.32%46.94%-54.28%
Return on Invested Capital (ROIC)
55.50%27.89%-24.25%9.34%147.52%-7309.06%
Return on Capital Employed (ROCE)
14.86%13.98%-9.68%-5.76%3.25%-61.96%
Earnings Yield
1.36%1.82%-1.14%17.36%-
FCF Yield
3.08%4.33%1.77%1.07%0.55%-
Buyback Yield / Dilution
-9.97%-10.58%0.69%-2.13%-2.69%-10.89%
Total Shareholder Return
-9.97%-10.58%0.69%-2.13%-2.69%-10.89%
SEC Filings: 10-K · 10-Q